Distributed synthetic data platform for AI applications
What is Neuromation?
Neurotoken (NTK) bonus pre-sale ends in
23:04:28:20
End date
28 Nov
POSITIVE
25%
bonus
Join the Whitelist now!
We care who our contributors are and how they want to participate in the Neuromation platform. Get whitelisted, contribute and get 25% bonus in neurotokens (NTK).
Surprise Bonus: In Addition next 5 (going fast, down from 10) whitelist participants will get a Surprise bonus on top of 25%. And first 1,000+ ETH contribution will get an even greater surprise!
Have a questions? Welcome to our Telegram!

awards

media about neuromation

"Mind blowing platform, a newborn baby giraffe, with the sexy genes she got from her mother! 7.8 out of 10"

Joshua Larson, Hacked.com.

our partners

Neurotoken (NTK) sale details

timing:

Oct 25th 2017
Presale starts (will need to register)
Nov 28th 2017
Sale starts
Jan 1st 2018
Sale ends (or 7 days after cap is reached)

timing bonus:

15%

in neurotokens (NTK)

first week

10%

in neurotokens (NTK)

second week

5%

in neurotokens (NTK)

third week

Neurotoken (NTK) details:

NeuroTokens (NTK) minted:

100,000,000

(Will not mint more)

Issued in NeuroToken (NTK) Sale: total available

60,000,000

Neuromation will burn unsold neurotokens (NTK)

NeuroToken (NTK) burn:

30%

2018

20%

2019

10%

2020

Neuromation will burn 50% of the neurotokens (NTK) over the next 3 years and decrease neurotoken (NTK) supply

Price per NeuroToken (NTK)

= 0.001 ETH

Neurotoken (NTK) distribution:

Neurotoken (NTK) sales proceeds distribution:

ICO proceeds distribution chart
  1. Al Least 40% for Platform Development
  2. Up to 40% Liquidity reverse (prepay for computing power)
  3. 10% for PR and Marketing of Neuromation service<
  4. 10% to partners / advisers /early backers

goals:

neuromation roadmap

Q1 2017

Seed round completed. Work started.

Q3 2017

Proof of hypothesis on synthetic data is finished. Retail synthetic data generator proven. Model development complete (95% of accuracy reached). Marketing and first sales to retail clients. Neurotoken (NTK) sales preparation.

Q1 2018

Active sales and marketing of Neuromation platform.
Neurotokens (NTK) are tradable on exchanges.
Industrial automation Lab is started.

Q3 2018

Neurotoken (NTK) will migrate to its own blockchain. Neuromation platform v3. Launched with 100,000 GPU capacity deployed.

Q4 2016

Team building.

Q1 2017

Seed round completed. Work started.

Q2 2017

Launch of R&D in Retail Lab test synthetic data hypothesis.

Q3 2017

Proof of hypothesis on synthetic data is finished. Retail synthetic data generator proven. Model development complete (95% of accuracy reached). Marketing and first sales to retail clients. Neurotoken (NTK) sales preparation.

Q4 2017

Neuromation Neurotoken (NTK) sales. Neuromation platform v1.
Launched with 1,000 GPU capacity deployed.
Medical devices Lab started.

Q1 2018

Active sales and marketing of Neuromation platform.
Neurotokens (NTK) are tradable on exchanges.
Industrial automation Lab is started.

Q2 2018

Neuromation platform v2. Launched with 10,000 GPU capacity deployed.

Q3 2018

Neurotoken (NTK) will migrate to its own blockchain. Neuromation platform v3. Launched with 100,000 GPU capacity deployed.

Beyond 2018 Neuromation is a definitive destination for businesses to develop their AI capability. Our Neurotokens (NTK) are the primary exchange mechanism enabling synthetic data generation, distributed model training, data labeling and other AI services.

We envision being a global resource pool for synthetic data. An ever growing library that would have data sets for every conceivable use case. As we tie in service providers into the platform, Neuromation will be an enabling ecosystem for all AI.